Literature DB >> 3420936

Adenylate cyclase activity as a predictor of thyroid tumor aggressiveness.

A E Siperstein, Q H Zeng, E T Gum, K E Levin, O H Clark.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3420936     DOI: 10.1007/BF01655441

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  14 in total

1.  Thyroid hormone action at the cell level (first of two parts).

Authors:  K Sterling
Journal:  N Engl J Med       Date:  1979-01-18       Impact factor: 91.245

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Suppressive therapy of nontoxic goiter.

Authors:  K Shimaoka; J E Sokal
Journal:  Am J Med       Date:  1974-10       Impact factor: 4.965

4.  A highly sensitive adenylate cyclase assay.

Authors:  Y Salomon; C Londos; M Rodbell
Journal:  Anal Biochem       Date:  1974-04       Impact factor: 3.365

5.  TSH suppression in the management of thyroid nodules and thyroid cancer.

Authors:  O H Clark
Journal:  World J Surg       Date:  1981-01       Impact factor: 3.352

6.  Do the prognoses of papillary and follicular thyroid carcinomas differ?

Authors:  J H Donohue; S D Goldfien; T R Miller; J S Abele; O H Clark
Journal:  Am J Surg       Date:  1984-07       Impact factor: 2.565

7.  Thyrotropin binding and adenylate cyclase activation in normal and neoplastic human thyroid tissue: lack of effect of thyroglobulin.

Authors:  O H Clark; P L Gerend; R A Nissenson
Journal:  J Clin Endocrinol Metab       Date:  1982-06       Impact factor: 5.958

8.  Prognostic value of nuclear DNA content in follicular thyroid tumours.

Authors:  M Bäckdahl; G Auer; G Forsslund; P O Granberg; B Hamberger; G Lundell; T Löwhagen; A Zetterberg
Journal:  Acta Chir Scand       Date:  1986-01

9.  Thyrotropin binding and adenylate cyclase stimulation in thyroid neoplasms.

Authors:  O H Clark; P L Gerend; T C Cote; R A Nissenson
Journal:  Surgery       Date:  1981-08       Impact factor: 3.982

10.  Further evidence of the validity of risk group definition in differentiated thyroid carcinoma.

Authors:  B Cady; R Rossi; M Silverman; M Wool
Journal:  Surgery       Date:  1985-12       Impact factor: 3.982

View more
  4 in total

Review 1.  Predictors of thyroid tumor aggressiveness.

Authors:  O H Clark
Journal:  West J Med       Date:  1996-09

Review 2.  Recurrent thyroid cancer.

Authors:  O H Clark
Journal:  J Endocrinol Invest       Date:  1995-02       Impact factor: 4.256

3.  Effect of somatostatin on adenylate cyclase activity in normal and neoplastic thyroid tissue.

Authors:  A E Siperstein; K E Levin; E T Gum; O H Clark
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

4.  Epidermal growth factor receptors and adenylate cyclase activity in human thyroid tissues.

Authors:  Q Y Duh; A E Siperstein; R A Miller; J J Sancho; M J Demeure; O H Clark
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.